14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Mar 22, 2021 $151.99 $155.33 $151.99 $155.25 2 321 129
Mar 19, 2021 $150.86 $151.78 $150.35 $150.94 2 534 819
Mar 18, 2021 $151.93 $153.09 $151.18 $151.27 2 256 285
Mar 17, 2021 $151.70 $153.69 $151.41 $153.23 2 466 707
Mar 16, 2021 $154.20 $155.67 $153.08 $153.37 4 696 110
Mar 15, 2021 $151.59 $152.23 $150.57 $152.18 2 367 182
Mar 12, 2021 $150.70 $151.78 $149.87 $151.59 1 657 562
Mar 11, 2021 $152.41 $152.76 $151.26 $151.45 3 166 369
Mar 10, 2021 $154.21 $154.97 $153.35 $153.48 2 924 006
Mar 09, 2021 $152.56 $153.77 $152.30 $152.61 3 887 762
Mar 08, 2021 $149.29 $151.11 $149.17 $150.06 3 196 414
Mar 05, 2021 $149.20 $150.56 $148.18 $150.10 3 054 895
Mar 04, 2021 $148.19 $150.15 $146.97 $148.46 3 899 949
Mar 03, 2021 $150.24 $150.63 $148.14 $148.19 3 431 326
Mar 02, 2021 $152.10 $152.69 $150.37 $150.37 2 346 055
Mar 01, 2021 $151.44 $153.58 $151.44 $151.97 3 222 014
Feb 26, 2021 $153.29 $153.86 $151.60 $152.75 2 218 554
Feb 25, 2021 $155.23 $155.48 $152.95 $153.65 1 797 500
Feb 24, 2021 $153.42 $155.09 $153.06 $154.49 3 572 396
Feb 23, 2021 $155.14 $155.41 $152.65 $152.93 2 394 437
Feb 22, 2021 $155.40 $155.70 $154.71 $154.81 3 577 611
Feb 19, 2021 $156.84 $157.30 $155.42 $155.51 2 054 300
Feb 18, 2021 $157.10 $157.99 $156.86 $157.58 1 989 301
Feb 17, 2021 $157.22 $158.41 $156.59 $157.02 2 390 781
Feb 16, 2021 $156.88 $157.35 $156.00 $156.69 1 333 771
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT